缩乳成形术中单剂与24小时抗生素预防:随机对照试验方案
本研究为缩乳成形术患者抗生素预防时长的非劣效性随机对照试验方案,计划纳入146例乳房肥大患者,随机分为麻醉诱导时单剂抗生素组和麻醉诱导时加术后24小时抗生素组,随访30天比较手术部位感染率,以验证24小时方案不优于单剂方案的假设。
要点
- 缩乳成形术预防性抗生素最佳时长缺乏证据,本研究比较单剂与24小时方案。
- 采用非劣效性设计,计划纳入146例,每组73例,随访30天评估感染。
- 感染判定采用美国CDC标准,出院后不再使用抗生素。
核心结论
- 研究将检验维持抗生素24小时相比单次术前剂量不降低感染率的假设。
研究设计与样本
- 随机、非劣效性试验,两组平行设计,计划纳入146例已安排缩乳成形术的乳房肥大患者。
- 患者随机分为安慰剂组(仅在麻醉诱导时接受抗生素,n=73)和抗生素组(麻醉诱导时及持续24小时接受抗生素,n=73)。
主要发现
- 原文未报告本研究结果。
关键数值与推荐
- 主要评价指标为术后30天内手术部位感染率,采用美国CDC标准判定。
- 出院后患者不再接受抗生素,每周随访一次持续30天。
临床怎么用
- 若单剂方案非劣效于24小时方案,可减少术后抗生素使用时长。
局限性
- 本文为研究方案,尚无结果数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reduction mammaplasty is among the most commonly performed procedures in plastic surgery. Antibiotics are widely prescribed, on an empirical basis, to prevent surgical site infections. However, there is a lack of evidence to support its use. This trial aims to compare the influence of the use of prophylatic antibiotics as a single dose or for 24 h on surgical site infection rates following reduction mammaplasty. METHODS: Randomized trial of non-inferiority, with two parallel groups. A total of 146 breast hypertrophy patients, with reduction mammaplasty already scheduled, will be enrolled. Patients will be randomly allocated to the placebo group that will receive antibiotics only at the anesthesia induction (n = 73) or to the antibiotics group that will receive antibiotics at the anesthesia induction and for 24 h (n = 73). None of the patients will receive antibiotics after hospital discharge. Patients will be followed-up weekly, for 30 days, regarding surgical site infection. The Centers for Disease Control and Prevention criteria will be applied. A statistical analysis of the data will be performed. DISCUSSION: Previous studies have demonstrated a decrease in infection rates after reduction mammaplasty when antibiotic prophylaxis was used, compared to the use of no antibiotics. However, the duration of antibiotic prophylaxis remains a point to be clarified. This study will test the hypothesis that maintaining the use of antibiotics for 24 h does not reduce infection rates compared to the use of a single preoperative dose. TRIAL REGISTRATION: Clinicaltrials.gov NCT04079686 . Registered on September 6, 2019.
引用
- Veiga DF, da Silva Garcia E, Moreira-Filho JW, et al. Single dose versus 24 h antibiotic prophylaxis in reduction mammaplasty: study protocol for a randomized controlled trial. Trials. 2020. PMID: 32616026. doi:10.1186/s13063-020-04539-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。